The molecular mechanism behind resistance of the kinase FLT3 to the inhibitor quizartinib
R Friedman - Proteins: Structure, Function, and Bioinformatics, 2017 - Wiley Online Library
Fms‐like tyrosine kinase 3 (FLT3) is a receptor tyrosine kinase that is a drug target for
leukemias. Several potent inhibitors of FLT3 exist, and bind to the inactive form of the …
leukemias. Several potent inhibitors of FLT3 exist, and bind to the inactive form of the …
The molecular mechanism behind resistance of the kinase FLT3 to the inhibitor quizartinib
R Friedman - Proteins, 2017 - pubmed.ncbi.nlm.nih.gov
Fms-like tyrosine kinase 3 (FLT3) is a receptor tyrosine kinase that is a drug target for
leukemias. Several potent inhibitors of FLT3 exist, and bind to the inactive form of the …
leukemias. Several potent inhibitors of FLT3 exist, and bind to the inactive form of the …
The molecular mechanism behind resistance of the kinase FLT3 to the inhibitor quizartinib.
R Friedman - Proteins, 2017 - europepmc.org
Fms-like tyrosine kinase 3 (FLT3) is a receptor tyrosine kinase that is a drug target for
leukemias. Several potent inhibitors of FLT3 exist, and bind to the inactive form of the …
leukemias. Several potent inhibitors of FLT3 exist, and bind to the inactive form of the …
The molecular mechanism behind resistance of the kinase FLT3 to the inhibitor quizartinib
R Friedman - Proteins: Structure, Function, and Bioinformatics, 2017 - diva-portal.org
Fms-like tyrosine kinase 3 (FLT3) is a receptor tyrosine kinase that is a drug target for
leukemias. Several potent inhibitors of FLT3 exist, and bind to the inactive form of the …
leukemias. Several potent inhibitors of FLT3 exist, and bind to the inactive form of the …